慢性淋巴细胞白血病 (CLL) 与边界免疫球蛋白重链突变状态,CLL的罕见子组与可变疾病过程
Francesco Angotzi1, Alessandro Cellini1, Valeria Ruocco1
1Hematology Unit, Department of Medicine, University of Padova, 35128 Padua, Italy.
Cancers
|March 28, 2024
概括
慢性淋巴细胞白血病 (CLL) 边缘突变免疫球蛋白重变量 (IGHV) 亚组显示治疗时间短,像未变异的IGHV,但整体存活率与突变的IGHV相似. 对这种罕见的CLL群体需要进一步的研究.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 慢性淋巴细胞白血病 (CLL) 的预后有很大的差异.
- 免疫球蛋白重变量 (IGHV) 突变状态是一个关键的预后因素,将患者分为突变 (M-IGHV) 和未突变 (U-IGHV) 组.
- 在大约5%的CLL病例中发现了一种罕见的边缘突变IGHV (BL-IGHV) 亚群.
研究的目的:
- 为了追溯分析BL-IGHV突变的CLL患者的临床结果.
- 为了比较M-IGHV和U-IGHV组的BL-IGHV患者的第一次治疗时间 (TTFT) 和整体存活率 (OS).
- 调查BL-IGHV亚组内潜在的共享生物特征.
主要方法:
- 在653名CLL患者的更大队列中,对30名BL-IGHV突变的CLL患者进行了回顾性分析.
- 在BL-IGHV,M-IGHV和U-IGHV患者组之间对TTFT和OS进行比较.
- 对预后因素和IGHV基因使用模式的分析.
主要成果:
- BL-IGHV患者表现出短时间的TTFT,与U-IGHV患者相比 (中位数为30.2个月与34个月).
- 对于BL-IGHV患者的OS与M-IGHV患者相似 (中位数NR与258个月).
- 尽管有类似的不良预后因素,但TTFT比其他已发表的队列更短,这表明了独特的生物特征.
结论:
- BL-IGHV突变的CLL患者具有独特的临床形象,需要早期治疗,但长期生存率有利.
- 共有的生物特征,包括IGHV基因使用,可能是这种罕见的CLL亚组的行为基础.
- 多中心研究对于更好地了解BL-IGHV CLL,优化治疗策略和改善对这一具有挑战性的群体的预测结果至关重要.
更多相关视频
15:07VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
Published on: December 28, 2015
26.7K
09:02Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
21.1K
相关概念视频
01:27Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
01:23Cells of the Adaptive Immune Response
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...